Chart calendar AstraZeneca PLC

dcade1efd6612096801518.tQJS65RReLd2MNqbvYclAvmz-BL3qiNvvAyHezZGVzw.0mAr2q02Atw9X-7x1PBRM5DgnUODzm8exnnUD1UNAXrvLyWd0CkL0ydGkw~fceac42d00d9ae167a3f9148b66bf0d2

Upcoming events on AstraZeneca PLC

2025-07-29 02:00 am Q2 2025 Earnings Release
2025-07-29 09:00 am Q2 2025 Earnings Call
2025-07-29 Roadshow - Goldman Sachs Day 1
2025-07-29 Roadshow - Morgan Stanley Day 1
2025-07-29 Roadshow - J.P. Morgan Day 1
2025-07-29 Roadshow - UBS Day 1
2025-07-30 Roadshow - J.P. Morgan Day 2
2025-07-30 Roadshow - Morgan Stanley Day 2
2025-07-30 Roadshow - Goldman Sachs Day 2
2025-07-30 Roadshow - UBS Day 2
2025-07-31 Roadshow - J.P. Morgan Day 3
2025-07-31 Roadshow - Goldman Sachs Day 3
2025-07-31 Roadshow - Morgan Stanley Day 3
2025-07-31 Roadshow - UBS Day 3
2025-08-25 Handelsbanken Life Science Innovation Day

Past events on AstraZeneca PLC

2025-07-08 Leerink Partners Therapeutics Forum
2025-07-02 Deutsche Bank Oncology R&D Leader Conference
2025-06-18 J.P. Morgan European Healthcare Forum
2025-06-08 Goldman Sachs Global Healthcare Conference
2025-06-02 07:30 pm American Society of Clinical Oncology Meeting
2025-05-28 08:00 am Business Update Call
2025-05-27 Roadshow
2025-05-26 Deutsche Bank dbAccess European Champions Conference
2025-05-21 Barclays European Leadership Conference
2025-05-21 02:12 pm American Thoracic Society International Conference
2025-05-21 01:03 pm American Thoracic Society International Conference
2025-05-20 Roadshow - UBS
2025-05-20 02:30 pm American Thoracic Society International Conference - P656
2025-05-20 02:30 pm American Thoracic Society International Conference - P330
2025-05-20 12:27 pm American Thoracic Society International Conference
2025-05-20 12:15 pm American Thoracic Society International Conference
2025-05-19 Roadshow - UBS Pre-market
2025-05-19 Berenberg European Conference
2025-05-19 05:15 pm American Thoracic Society International Conference - 1023
2025-05-19 05:15 pm American Thoracic Society International Conference - 1008

Past dividends on AstraZeneca PLC

2025-02-19 Final Payment 1.68 GBP
2024-08-07 Interim Payment 0.776 GBP
2024-02-21 Final Payment 1.56 GBP
2023-08-09 Interim Payment 0.718 GBP
2023-02-22 Final Payment 1.628 GBP
2022-08-10 Interim Payment 0.764 GBP
2022-02-23 Final Payment 1.453 GBP
2021-08-11 Interim Payment 0.648 GBP
2021-02-24 Final Payment 1.374 GBP
2020-08-12 Interim Payment 0.696 GBP
2020-02-26 Final Payment 1.464 GBP
2019-08-07 Interim Payment 0.719 GBP
2019-02-27 Final Payment 1.468 GBP
2018-08-08 Interim Payment 0.684 GBP
2018-02-14 Final Payment 1.336 GBP
2017-08-09 Interim Payment 0.689 GBP
2017-02-15 Final Payment 1.502 GBP
2016-08-10 Interim Payment 0.687 GBP
2016-02-17 Final Payment 1.31 GBP
2015-08-12 Interim Payment 0.575 GBP

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million USD
Released
Forecast
Spread
44 351
44 465
-0.26%
45 811
45 716
0.21%
54 073
53 340
1.37%

57 697


61 274


64 696

EBITDA
Million USD
Released
Forecast
Spread
9 237
13 681
-32.49%
13 580
15 477
-12.26%
16 691
16 909
-1.29%

19 616


22 137


24 274

EBIT
Million USD
Released
Forecast
Spread
13 350
13 702
-2.57%
14 534
15 036
-3.34%
16 928
17 034
-0.63%

18 511


20 872


23 019

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
2 501
3 511
-28.78%
6 899
9 269
-25.57%
8 691
10 318
-15.77%

12 736


15 325


17 312

Net income
Million USD
Released
Forecast
Spread
3 288
4 262
-22.86%
5 961
6 597
-9.64%
7 035
8 172
-13.91%

9 862


11 907


13 335

EPS
USD
Released
Forecast
Spread
2,11
2,81
-24.96%
3,81
4,34
-12.22%
4,50
5,33
-15.6%

6,33


7,66


8,69

Announcement Date09/02/2308/02/2406/02/25-

Quarterly results

Fiscal PeriodMarch 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Million USD
Released
Forecast
Spread
11 492
11 529
-0.32%
12 024
12 007
0.14%
12 679
11 812
7.34%
12 938
12 528
3.28%
25 617
12 560
103.96%
13 565
13 102
3.53%
14 891
14 181
5.01%
13 588
13 741
-1.11%

14 061


14 558


15 320


14 260


14 597


15 134


15 859

EBITDA
Million USD
Released
Forecast
Spread









4 025
4 305
-6.51%



3 923
4 265
-8.01%
4 373
5 435
-19.54%
4 958
5 324
-6.87%

4 284


4 707


4 375













EBIT
Million USD
Released
Forecast
Spread
3 545
3 537
0.24%
2 752
3 206
-14.15%
4 310
3 911
10.2%
4 101
4 016
2.11%
8 411
4 052
107.58%
4 318
4 177
3.37%
4 199
4 300
-2.34%
4 803
4 583
4.81%

4 437


4 521


4 390













Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
1 652
2 510
-34.17%
897
1 671
-46.32%
2 800
2 296
21.95%
2 397
2 395
0.08%



1 828
2 873
-36.37%
1 666
2 825
-41.03%
























Net income
Million USD
Released
Forecast
Spread
1 378
1 705
-19.16%
959
2 313
-58.53%
2 179
2 065
5.52%
1 927
2 130
-9.52%



1 429
2 332
-38.72%
1 500
3 284
-54.32%
2 916
2 458
18.63%

2 466


2 647


2 236













EPS
USD
Released
Forecast
Spread
0,89
1,09
-18.64%
0,62
1,49
-58.3%
1,41
1,33
6.28%
1,24
1,36
-9%



0,91
1,49
-39.13%
0,96
2,11
-54.44%
1,88
1,57
19.47%

1,58


1,70


1,44













Announcement Date09/11/2308/02/2425/04/2425/07/2425/07/2412/11/2406/02/2529/04/25-------

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AZN Stock
  4. Calendar AstraZeneca PLC